Buy It or Sell It? CloudMD Software & Services Inc (OTCMKTS:DOCRF) (CVE:DOC)
CloudMD Software & Services Inc (OTCMKTS:DOCRF) (CVE:DOC) stock ended lower on low volume Tuesday. The company released news this morning. The stock could be in action on Wednesday.
Major Trigger:
CloudMD Appoints Karen Adams as President and Provides Update on Oncidium Acquisition
Key Highlights:
- DOCRF announced the appointment of Karen Adams as President of the Company effective June 21, 2021. In her new role as President of CloudMD, Karen will deliver on the Company’s growth strategy and operational effectiveness, while leveraging technology to enable access to care. Karen will continue to oversee Employee Health Solutions (“EHS”) as a core component of her expanded portfolio.
- The Company’s previous President, Dr. Amit Mathur, will now take on the primary responsibility of delivering CloudMD’s expansion into the United States, a key component of the corporate strategy. Dr. Mathur’s appointment to the newly created leadership role of President, US Operations is effective June 21, 2021.
Key Quote:
“Our Company is rapidly growing and I am very proud of the entire team on its ability to continue executing and delivering on our growth strategy. The increasingly complex landscape of the public and private healthcare sector supports our mission of building one, connected healthcare ecosystem through navigation, coordination and seamless delivery of services that addresses all points of a patient’s care,” explained Dr. Essam Hamza, Chief Executive Officer of CloudMD.
Market Reaction
In the previous trading session, DOCRF stock fell 2% to $1.47. Total volume for the session stood at 89K shares, below its average volume of 211K shares. The stock moved within a range of $1.4500 – 1.5000.
